Welcome to our dedicated page for Phibro Animal news (Ticker: PAHC), a resource for investors and traders seeking the latest updates and insights on Phibro Animal stock.
Phibro Animal Health Corporation (Nasdaq: PAHC) is a diversified global animal health and nutrition company with operations across Animal Health, Mineral Nutrition, and Performance Products. This news page aggregates company-issued updates and other coverage related to PAHC stock, helping readers follow developments that Phibro discloses through press releases and regulatory communications.
Phibro’s news flow frequently includes financial results and guidance, such as quarterly and full-year earnings releases and updates to financial outlook for future fiscal years. These announcements often detail net sales by segment, trends in medicated feed additives (MFAs), nutritional specialty products, vaccines, mineral nutrition products, and performance products, as well as commentary on factors like product demand, foreign currency impacts, and operating expenses.
Investors can also expect corporate and strategic announcements, including information about acquisitions or portfolio additions, such as the referenced MFA portfolio acquired from Zoetis, Inc., and enterprise programs like Phibro Forward, which the company describes as focused on efficiency, growth, and cultural engagement. Leadership and governance updates, including planned executive transitions and matters presented at the annual meeting of stockholders, are typically communicated through press releases and accompanying SEC filings.
Product and pipeline-related news is another key category. Phibro has highlighted developments in companion animal oral health, including the licensing agreement with Lighthouse Pharmaceuticals, Inc. for a proprietary compound for canine periodontal care and the national launch of Restoris piezoelectric dental gel for dogs with periodontal disease. Such releases describe product mechanisms, study results, and distribution plans.
In addition, Phibro issues dividend declarations, notices of participation in investor conferences, and details on upcoming webcasts and conference calls to discuss results. Readers interested in PAHC can use this page to monitor these recurring updates and review the company’s own descriptions of its performance, strategy, and product initiatives.
Phibro Animal Health Corporation (Nasdaq: PAHC) announced its participation in the upcoming Morgan Stanley Annual Global Healthcare Conference. CFO Glenn David will present to financial analysts and investors on September 9, 2025, at 12:20 PM ET at the Sheraton New York Times Square Hotel.
The presentation will be accessible via live audio stream on the company's investor relations website, with a replay available for later viewing.
Phibro Animal Health (NASDAQ:PAHC) reported strong financial results for Q4 and fiscal year 2025, with significant growth across key metrics. The company achieved Q4 net sales of $378.7M (up 39%) and net income of $17.2M (up $16.5M), with diluted EPS of $0.42.
For FY2025, PAHC reported net sales of $1.29B (up 27%), net income of $48.3M, and adjusted EBITDA of $183.7M (up 65%). The growth was primarily driven by the successful integration of the Zoetis MFA portfolio and strong performance across Animal Health segments.
Looking ahead, PAHC provided FY2026 guidance with projected net sales of $1.43-1.48B and adjusted EBITDA of $225-235M, reflecting continued confidence in their growth trajectory.
Phibro Animal Health Corporation (Nasdaq: PAHC) has scheduled its fourth quarter and fiscal year 2025 financial results announcement for Wednesday, August 27, 2025, after market close. The company will host a conference call and webcast to discuss the results on Thursday, August 28, 2025, at 9:00 AM Eastern Time.
Investors can access the presentation through the company's investor relations website at https://investors.pahc.com or join via phone using the provided dial-in numbers. A replay of the webcast will be made available approximately two hours after the event concludes.
Phibro Animal Health Corporation (Nasdaq: PAHC) has announced a quarterly dividend declaration. The company's Board of Directors has approved a cash dividend of $0.12 per share for both Class A and Class B common stock. The dividend will be paid on September 24, 2025, to shareholders who are registered as of September 3, 2025.
Phibro Animal Health Corporation (NASDAQ: PAHC) has announced its participation in the upcoming Stifel Jaws & Paws Conference. The company's Chief Operating Officer Larry Miller and Director and Executive Vice President of Corporate Strategy Daniel Bendheim will present to financial analysts and investors on Thursday, May 29, 2025, at 8:35 AM ET at the Lotte New York Hotel. The presentation will be accessible via live audio stream on Phibro's investor relations website, with a replay available for later viewing.
Phibro Animal Health Corporation (NASDAQ: PAHC) has announced a quarterly cash dividend declaration. The company's Board of Directors has approved a dividend payment of $0.12 per share for both Class A and Class B common stock. The dividend will be paid on June 25, 2025, to stockholders who are registered as of the close of business on June 4, 2025.
Phibro Animal Health (Nasdaq: PAHC) has scheduled its third quarter financial results announcement for Wednesday, May 7, 2025, after market close. The company will hold a conference call and webcast to discuss the results on Thursday, May 8, 2025, at 9:00 AM Eastern Time.
Investors can access the presentation slides and webcast through https://investors.pahc.com. The conference call will be available via phone at +1 (888) 330-2022 for U.S. and Canada callers, or +1 (365) 977-0051 for international participants, using conference ID 3927884. A replay of the webcast will be made available approximately two hours after the event concludes.
Phibro Animal Health (Nasdaq: PAHC) has announced its participation in the upcoming Barclays Annual Global Healthcare Conference. Chief Financial Officer Glenn David will present to financial analysts and investors on Thursday, March 13, 2025, at 9:00 AM ET at the Loews Miami Beach Hotel.
The presentation will be accessible through a live audio stream on the company's investor relations website at https://investors.pahc.com. For those unable to attend, a replay of the session will be made available and archived on the same platform.
Phibro Animal Health (Nasdaq: PAHC) has announced its participation in the upcoming Bank of America 2025 Virtual Animal Health Summit. The company's Chief Financial Officer, Glenn David, will present to financial analysts and investors on Thursday, February 27, 2025, at 10:50 AM ET.
The presentation will be accessible through a live audio stream on Phibro's Investor Relations website at investors.pahc.com. For those unable to attend the live session, a replay will be made available and archived on the company's website for future reference.